Represented Blues plans and other health insurers in litigation against drug manufacturers for overpayments made for the prescription drug buspar on claims which included allegations of antitrust violations arising from manufacturers’ use of patents and the FDA regulations in conjunction with the Hatch-Waxman Act to keep generics out of the market, settlement obtained for plaintiffs.
Anthem Blue Cross Blue Shield
Blue Cross and Blue Shield of Florida, Inc.
Blue Cross and Blue Shield of Louisiana
Blue Cross and Blue Shield of Massachusetts
Blue Cross Blue Shield of Michigan
Blue Cross Blue Shield of Minnesota
Blue Cross Blue Shield of Nebraska
Blue Cross Blue Shield of Oklahoma
Blue Cross Blue Shield of Tennessee
Blue Shield of California
Carefirst, Inc., Excellus Health Plan, Inc.
The Guardian Life Insurance Company of America
Hawaii Medical Service Association
Health Care Service Corporation
Horizon Blue Cross Blue Shield of New Jersey, Humana, Inc.
Mutual of Omaha, Regence Blue Shield of Idaho
Wellchoice, Inc., Wellmark, Inc. V. Bristol-Myers Squibb, et al
